Healthcare • Biotechnology
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States.
The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Company profile from EODHD, stored Oct 24, 2026.
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 6, 2026 | $5.9M | -53.8% | 85.0% | -$13.1M | -$13.2M |
| Mar 2026filed May 12, 2026 | $5.0M | +46.1% | 82.3% | -$9.7M | -$9.7M |
| Dec 2025filed Mar 11, 2026 | $5.1M | +1,380.2% | 72.5% | -$6.9M | -$8.1M |
| Sep 2025filed Nov 14, 2025 | $14.3M | — | 92.3% | $1.6M | -$274.0K |
| Jun 2025filed Aug 12, 2025 | $12.7M | +145.4% | 96.1% | $1.5M | $204.0K |
| Mar 2025filed May 13, 2025 | $3.4M | -10.1% | 87.7% | -$8.1M | -$9.7M |
| Dec 2024filed Mar 11, 2025 | $344.0K | -82.7% | -81.7% | -$11.4M | -$16.2M |
| Sep 2024filed Nov 5, 2024 | — | — | — | -$20.7M | -$22.9M |
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 11, 2026 | $35.6M | +370.2% | 90.3% | -$11.9M | -$17.9M |
| Dec 2024filed Mar 11, 2025 | $7.6M | +47.7% | 63.8% | -$65.9M | -$76.6M |
| Dec 2023filed Feb 29, 2024 | $5.1M | -43.3% | 85.4% | -$65.8M | -$67.0M |
| Dec 2022filed Mar 6, 2023 | $9.0M | -24.7% | 92.0% | -$21.3M | -$24.5M |
| Dec 2021filed Mar 2, 2022 | $12.0M | 0.0% | 96.1% | -$30.9M | -$35.1M |
| Dec 2020filed Mar 17, 2021 | $12.0M | — | — | -$40.2M | -$45.5M |
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched VRCA. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
192,613 shares short
-3,608 shares (-1.8%) vs Sep 30, 2026
1.6% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
196,221 shares short
-6,534 shares (-3.2%) vs Sep 15, 2026
2.5% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
202,755 shares short
-19,817 shares (-8.9%) vs Aug 31, 2026
3% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
222,572 shares short
-46,777 shares (-17.4%) vs Aug 14, 2026
3.3% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
269,349 shares short
-18,398 shares (-6.4%) vs Jul 31, 2026
4% of the stored float. Published Aug 25, 2026.
Settlement Jul 31, 2026
287,747 shares short
-28,013 shares (-8.9%) vs Jul 15, 2026
4.2% of the stored float. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
See the recorded cash amounts and dates behind VRCA’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
1 for 10 · reverse split
Effective Jul 25, 2025
Each 10 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workSign in to see your position size
We’ll show you if VRCA is in your portfolio and how much it contributes.
Sign inLoading market dates
9 smart-money holders: institutions with a high Holder IQ
Smart-money 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bullish
Last trade: buy 81 days ago
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
Stored recent-activity label: bullish. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 1
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
Stored recent-activity label: bullish. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
43 filers reported a long position in VRCA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
92.1%
of the 4.7M shares 13-F filers reported
Moves vs Q1 2026
4 added2 trimmed
4 unchanged
Net shares held
+7.9%
across the 10 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Caligan Partners LP | $5.7M · 923.9K shares | 923.9K | Unchanged |
| 2 | CANNELL CAPITAL LLC | $4.8M · 783.9K shares | 783.9K | +14.4% |
| 3 | Affinity Asset Advisors, LLC | $4.3M · 707.3K shares | 707.3K | Unchanged |
| 4 | Velan Capital Investment Management LP | $2.9M · 471.6K shares | 471.6K | Unchanged |
| 5 | ARMISTICE CAPITAL, LLC | $2.6M · 426.3K shares | 426.3K | -17.7% |
| 6 | BOOTHBAY FUND MANAGEMENT, LLC | $1.7M · 280.7K shares | 280.7K | Unchanged |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | $1.7M · 279.3K shares | 279.3K | +48% |
| 8 | Mariner, LLC | $1.3M · 207.2K shares | 207.2K | +744.3% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $845.7K · 138.2K shares | 138.2K | -0.5% |
| 10 | BlackRock, Inc. | $455K · 74.3K shares | 74.3K | +92.8% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inUnlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.